Based on our successful first edition in 2024, MD.be s pleased to announce the second Belgian cfDNA Oncology Meeting, taking place on 26 November 2026 at the Pullman hotel in Brussels.The meeting aims to inform you about the latest developments in the fast-growing field of cfDNA analysis, with a focus on Belgian initiatives in research and diagnostics in oncology.
Final program and registration: https://tempocongress.com/2026/molecular_diagnostic/
The meeting will start at 9:30h and will end with a closing reception at 16:15h.
Confirmed speakers and topics:
- Jo Vandesompele, Ghent University (cfRNA analysis)
- Isabelle Vanden Bempt, UZ Leuven ( OncoXPLORE platform)
- Ken Op de Beeck, Antwerp University (Methylation Profiling on cfDNA)
- Kristof Cuppens, Jessa Hospital Hasselt (NEOPREDICT–EGFR study)
- Bernard Thienpont, KU Leuven (Methylome and fragmentome profiling)
- Remond Fijneman, NKI, Amsterdam (PROVENC study)
- Etienne Rouleau, Gustave Roussy, Paris (ctDNA analysis in France)
- Sponsored talk by Astra Zeneca (BRAC1/2 in prostate cancer)
- 4 talks selected from abstracts
Call for abstracts
We also reserve 4 slots of 15 min for selected abstracts from PhD students and early post-docs. Please submit your abstract (max 300 words) to guy.froyen@jessazh.be before October 24. The selection will be performed by the organizing committee, and you will be notified before November 11.